Differences in platelet microRNA profiles after aspirin use are associated with differences in whole blood aggregation and might identify aspirin resistance

被引：0
|
作者：
Kok, M. G. [1 ]
Mandolini, C. [2 ]
Nieuwland, R. [3 ]
Creemers, E. [4 ]
Meijers, J. C. [1 ]
Pinto, S-J [5 ]
机构：
[1] Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands
[2] Univ Amsterdam, Acad Med Ctr, Dept Expt Vasc Med, NL-1105 AZ Amsterdam, Netherlands
[3] Univ Amsterdam, Acad Med Ctr, Dept Clin Chem, NL-1105 AZ Amsterdam, Netherlands
[4] Univ Amsterdam, Acad Med Ctr, Heart Failure Res Ctr, NL-1105 AZ Amsterdam, Netherlands
[5] Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, NL-1105 AZ Amsterdam, Netherlands
来源：
JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2013年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：634 / 634
页数：1
相关论文
共 50 条
  • [1] DIFFERENCES IN PLATELET microRNA PROFILES AFTER ASPIRIN USE ARE ASSOCIATED WITH DIFFERENCES IN WHOLE BLOOD AGGREGATION AND MIGHT IDENTIFY ASPIRIN RESISTANCE
    Kok, M. G.
    Mandolini, C.
    Nieuwland, R.
    Creemers, E. E.
    Meijers, J. C.
    Pinto-Sietsma, S. J.
    CARDIOLOGY, 2013, 125 : 345 - 345
  • [2] Differences in platelet microRNA profiles after aspirin use are associated with differences in whole blood aggregation and might identify aspirin resistance
    Kok, M. G. M.
    Mandolini, C.
    Nieuwland, R.
    Creemers, E. E.
    Meijers, J. C. M.
    Pinto-Sietsma, S. J.
    EUROPEAN HEART JOURNAL, 2013, 34 : 892 - 892
  • [3] Changes in miR-B expression after aspirin use are correlated to the extent of reduction in platelet aggregation and might identify aspirin insensitivity
    Kok, M. G. M.
    Mandolini, C.
    Nieuwland, R.
    Creemers, E. E.
    Meijers, J. C. M.
    Pinto-Sietsma, S. J.
    EUROPEAN HEART JOURNAL, 2014, 35 : 350 - 350
  • [4] Differences in Whole Blood Platelet Aggregation at Baseline and in Response to Aspirin and Aspirin Plus Clopidogrel in Patients With Versus Without Chronic Kidney Disease
    Jain, Nishank
    Li, Xilong
    Adams-Huet, Beverley
    Sarode, Ravi
    Toto, Robert D.
    Banerjee, Subhash
    Hedayati, S. Susan
    AMERICAN JOURNAL OF CARDIOLOGY, 2016, 117 (04): : 656 - 663
  • [5] PLATELET-AGGREGATION IN HUMAN WHOLE-BLOOD AFTER CHRONIC ADMINISTRATION OF ASPIRIN
    DELACRUZ, JP
    CAMARA, S
    BELLIDO, I
    CARRASCO, T
    DELACUESTA, FS
    THROMBOSIS RESEARCH, 1987, 46 (01) : 133 - 140
  • [6] Fucoidan is nearly as effective as aspirin in inhibiting platelet aggregation in whole blood
    Davidson, L
    McDonagh, P
    Nolan, P
    Ritter, L
    FASEB JOURNAL, 2005, 19 (05): : A1083 - A1083
  • [7] INHIBITION OF PLATELET-AGGREGATION IN WHOLE-BLOOD BY DIPYRIDAMOLE AND ASPIRIN
    HEPTINSTALL, S
    FOX, S
    CRAWFORD, J
    HAWKINS, M
    THROMBOSIS RESEARCH, 1986, 42 (02) : 215 - 223
  • [8] Normalisation of platelet aggregation after cessation of aspirin with whole blood aggregometry and in vitro bleeding time
    von Pape, K. -W.
    Calatzis, A.
    Weisser, H.
    HAMOSTASEOLOGIE, 2009, 29 : S111 - S112
  • [9] Determination of aspirin responsiveness by use of whole blood platelet aggregometry
    Ivandic, Boris T.
    Giannitsis, Evangelos
    Schlick, Philipp
    Staritz, Peter
    Katus, Hugo A.
    Hohlfeld, Thomas
    CLINICAL CHEMISTRY, 2007, 53 (04) : 614 - 619
  • [10] Measurement of whole blood platelet aggregation by Multiplate® aggregometry before and during aspirin treatment
    Pedersen, Susanne B.
    Kristensen, Steen D.
    Hvas, Anne-Mette
    BLOOD, 2007, 110 (11) : 41B - 41B
12345